Index Option Calls
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Index Option Calls
No Result
View All Result
Home Latest News

Biden picks former FDA Commissioner Dr. Robert Califf to run the agency

by
November 12, 2021
in Latest News
0
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

Jamie Dimon is being deposed over JPMorgan Chase role in Epstein lawsuits

Here’s where to invest $10,000 right now, according to the pros

Dr. Robert Califf testifies during his nomination hearing before the Senate Health, Education, Labor and Pensions Committee November 17, 2015 in Washington, DC.

Win McNamee | Getty Images

President Joe Biden announced Friday he has nominated Dr. Robert Califf to serve as the chief of the Food and Drug Administration.

The FDA, currently overseen by acting Commissioner Woodcock, has been without a permanent chief since Biden took office in January. The White House reportedly ruled out Woodcock after she faced opposition from some members of Congress over her handling of opioids while at the agency.

“I first want to thank Dr. Janet Woodcock for her leadership over the last year,” Biden said in a statement. “She has done an incredible job leading the agency during what has been a busy and challenging time, and both she and the FDA career staff have worked hard and followed the science to ensure the American public can trust the decisions being made by the FDA.”

Califf, a cardiologist who works at the Duke University School of Medicine and Google parent Alphabet’s life sciences organization, was briefly the agency’s commissioner under the Obama administration beginning in 2016. He also served as deputy commissioner of the FDA’s medical products and tobacco office.

Biden said Friday that Califf had “strong bipartisan support” in the Senate in 2016 when he was confirmed with a vote of 89 to 4. “I urge the Senate to swiftly confirm Dr. Califf so he can continue the important work being done at this critical moment,” the president said.

The new selection was expected imminently because Woodcock cannot legally stay on as the acting head past Nov. 15 without a nominee to hold the position permanently.

Shortly after Biden announced his pick, Democratic Sen. Joe Manchin of West Virginia criticized the decision, saying it made “no sense” as he claimed Califf has “significant ties to the pharmaceutical industry.”

“His nomination is an insult to the many families and individuals who have had their lives changed forever as a result of addiction. I could not support Dr. Califf’s nomination in 2016 and I cannot support it now,” Manchin said.

Biden’s nomination comes amid the ongoing Covid pandemic, which has killed at least 759,678 Americans, according to data compiled by Johns Hopkins University.

The FDA has helped bring lifesaving treatments to the market and authorized the use of Covid vaccines, which have shown to be highly effective, especially against severe disease, hospitalization and death.

More than 194 million Americans are fully vaccinated against Covid, according to data compiled by the Centers for Disease Control and Prevention.

The FDA has recently come under harsh criticism, though, over its decision to approve Biogen’s Alzheimer’s drug, Aduhelm.

ShareTweetPin

Related Posts

Jamie Dimon is being deposed over JPMorgan Chase role in Epstein lawsuits

by
March 29, 2023
0

Jamie Dimon, chairman and chief executive officer of JPMorgan Chase & Co., during a Bloomberg Television interview at the JPMorgan...

Here’s where to invest $10,000 right now, according to the pros

by
March 29, 2023
0

Markets have been hit by volatility over the past month leading some retail investors to question where to park their...

Mortgage demand gets a boost from bank volatility, but it may be short-lived

by
March 29, 2023
0

An 'open house' flag is displayed outside a single family home on September 22, 2022 in Los Angeles, California. Allison...

Bitcoin climbs 5% above $28,000 as investors shrug off regulatory crackdowns

by
March 29, 2023
0

In this article BTC.CM= Follow your favorite stocksCREATE FREE ACCOUNT Bitcoin is up 50% so far in 2023, beating major...

IHOP overhauls its menu: Cinn-A-Stack pancakes are back, savory crepes are in

by
March 29, 2023
0

In this article DIN Follow your favorite stocksCREATE FREE ACCOUNT IHOP's new crepe lineup features sweet and savory flavors. Source:...

Next Post

Notable insiders like Elon Musk and Adam Aron are selling. Should you follow them?

Stocks making the biggest moves midday: Tesla, Lordstown Motors, Warby Parker and more

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:

By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • A Couple Stored IRA Gold at Home. They Owe the IRS More Than $300,000.

    0 shares
    Share 0 Tweet 0
  • A California Couple Spent Eight Years Building Their Dream Retirement Home in Costa Rica

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs says buy these stocks to play Web 3.0 and the metaverse

    0 shares
    Share 0 Tweet 0
  • In his final warning, this stock trading wizard — who made big money in bear markets and crashes — called this market a bubble like no other

    0 shares
    Share 0 Tweet 0
  • Goldman Sachs picks new stocks to buy — and says these 5 have over 100% upside

    0 shares
    Share 0 Tweet 0
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by www.indexoptioncalls.com
No Result
View All Result
  • Home
  • Latest News
  • Email Whitelisting
  • Privacy Policy

All rights reserved by www.indexoptioncalls.com